The Liver Meeting 2026
Roundtable Meet the Expert track
MTE #15: Ileal Bile Acid Transporter Inhibitors for Cholestatic Liver Disease—Therapeutic Promise for Symptoms and Disease Modification? (Ticketed)
Sat, Nov 7, 2026 · 12:45–1:30 PM MST Convention Center: Room 1A, Colorado Convention Center
About this session
Ileal bile acid transporter (IBAT) inhibitors have emerged as a novel and increasingly relevant therapeutic class in the management of cholestatic liver diseases. Initially developed to address cholestatic pruritus through interruption of enterohepatic bile acid circulation, these agents have demonstrated meaningful symptomatic benefit across multiple cholestatic conditions.
Speaker
-
Stanford University Medical Center
Facilitator